Back
Kymera Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
78
KYMR
Kymera Therapeutics, Inc.
Last Price:
$83.94
Seasonality Move:
-2.06%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Kymera Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 85.37 | Sell |
| 20-day SMA: | 76.38 | Buy |
| 50-day SMA: | 67.14 | Buy |
| 200-day SMA: | 46.64 | Buy |
| 8-day EMA: | 82.78 | Buy |
| 20-day EMA: | 77.85 | Buy |
| 50-day EMA: | 68.99 | Buy |
| 200-day EMA: | 52.52 | Buy |
Kymera Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.67 | Buy |
| Relative Strength Index (14 RSI): | 61.09 | Buy |
| Chaikin Money Flow: | 904128 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (63.53 - 84.49) | Buy |
| Bollinger Bands (100): | (43.76 - 70.14) | Buy |
Kymera Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Kymera Therapeutics, Inc. Stock
Is Kymera Therapeutics, Inc. Stock a Buy?
-
Kymera Therapeutics, Inc. share price is 83.99 while KYMR 8-day simple moving average is 85.37, which is a Sell signal.
-
The stock price of KYMR is 83.99 while Kymera Therapeutics, Inc. 20-day SMA is 76.38, which makes it a Buy.
-
Kymera Therapeutics, Inc. 50-day simple moving average is 67.14 while KYMR share price is 83.99, making it a Buy technically.
-
KYMR stock price is 83.99 and Kymera Therapeutics, Inc. 200-day simple moving average is 46.64, creating a Buy signal.
KYMR Technical Analysis vs Fundamental Analysis
Buy
78
Kymera Therapeutics, Inc. (KYMR)
is a Buy
Is Kymera Therapeutics, Inc. a Buy or a Sell?
-
Kymera Therapeutics, Inc. stock is rated a BuyThe current Kymera Therapeutics, Inc. [KYMR] share price is $83.99. The Score for KYMR is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
Kymera Therapeutics, Inc. Stock Info
Market Cap:
6B
Price in USD:
83.99
Share Volume:
1.5M
Kymera Therapeutics, Inc. 52-Week Range
52-Week High:
103.00
52-Week Low:
19.45
Buy
78
Kymera Therapeutics, Inc. (KYMR)
is a Buy
Kymera Therapeutics, Inc. Share Price Forecast
-
What is the Kymera Therapeutics, Inc. stock price today?The Kymera Therapeutics, Inc. stock price is 83.99 USD today.
-
Will KYMR stock go up or go down?Kymera Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Kymera Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Kymera Therapeutics, Inc. is not overvalued.
Is Kymera Therapeutics, Inc. Stock a Buy?
-
Kymera Therapeutics, Inc. share price is 83.99 while KYMR 8-day exponential moving average is 82.78, which is a Buy signal.
-
The stock price of KYMR is 83.99 while Kymera Therapeutics, Inc. 20-day EMA is 77.85, which makes it a Buy.
-
Kymera Therapeutics, Inc. 50-day exponential moving average is 68.99 while KYMR share price is 83.99, making it a Buy technically.
-
KYMR stock price is 83.99 and Kymera Therapeutics, Inc. 200-day simple moving average is 52.52, creating a Buy signal.
Fundamental Analysis of Kymera Therapeutics, Inc.
Is Kymera Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.62 per share, and a decrease next year of $0.27 per share.
Technical Analysis of Kymera Therapeutics, Inc.
Should I short Kymera Therapeutics, Inc. stock?
-
KYMR Moving Average Covergence Divergence (MACD) indicator is 5.67, suggesting Kymera Therapeutics, Inc. is a Buy
-
Kymera Therapeutics, Inc. Relative Strength Index (RSI) is 61.09, which suggest Kymera Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Kymera Therapeutics, Inc. is (63.53 - 84.49), which suggest Kymera Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Kymera Therapeutics, Inc. is (43.76 - 70.14), which suggest Kymera Therapeutics, Inc. is a Buy
* Kymera Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.